Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2025.
It does not necessarily reflect the opinion of the European Society of Cardiology.
Funding: This work was supported by the Swedish Research Council, the Swedish Heart and Lung Foundation and Region Västra Götaland.
Disclosures: Professor Nordanstig and Professor Falkenberg report no disclosures related to this work.
References and notes:
1‘SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease’ presented during HOT LINE 6 on 31 August 2025 at 08:15 to 08:25 in Madrid (Main Auditorium).
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
Follow European Society of Cardiology News on LinkedIn
The hashtag for ESC Congress 2025 is #ESCCongress
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
About ESC Congress 2025
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.
About the European Society of Cardiology
The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.